骨吸收标志物可预测绝经过渡期股骨颈尺寸与强度变化速率
本研究基于SWAN队列696名多族裔社区女性,评估绝经过渡早期尿I型胶原N端肽(U-NTX)与股骨颈宽度(FNW)及压缩强度指数(CSI)、冲击强度指数(ISI)变化速率的关联。结果显示,骨吸收水平每增加1个标准差,FNW年增幅减慢0.2%(p=0.03),CSI年下降加快0.3%(p=0.02),ISI年下降加快0.3%(p=0.01);与股骨颈骨密度下降速率无关联。
要点
- 绝经过渡早期骨吸收水平越高,股骨颈宽度增加越慢(每SD年减慢0.2%,p=0.03)。
- 骨吸收水平越高,股骨颈压缩强度指数与冲击强度指数下降越快(每SD年加快0.3%,p=0.02和p=0.01)。
- 骨吸收标志物与绝经过渡期股骨颈骨密度下降速率无关联。
核心结论
- 在绝经过渡早期测量骨吸收标志物,可能识别出绝经过渡期骨强度损失最大的女性。
研究设计与样本
- 概念验证研究,使用SWAN纵向研究中696名多族裔社区居住女性的既往骨吸收标志物(尿I型胶原N端肽,U-NTX)与股骨颈强度数据。
主要发现
- 校正绝经过渡分期(绝经前 vs. 早期围绝经期)、年龄、BMI、标志物采集时间和研究中心后,绝经前及早期围绝经期骨吸收与绝经过渡期股骨颈骨密度下降速率无关联。
- 骨吸收水平每增加1个标准差,股骨颈宽度年增幅减慢0.2%(p=0.03),CSI年下降加快0.3%(p=0.02),ISI年下降加快0.3%(p=0.01)。
- 仅限早期围绝经期女性时,骨吸收与FNW、CSI、ISI变化的关联与全样本相似。
关键数值与推荐
- 骨吸收水平每增加1个标准差:FNW年变化减慢0.2%(p=0.03);CSI年下降加快0.3%(p=0.02);ISI年下降加快0.3%(p=0.01)。
临床怎么用
- 在绝经前和早期围绝经期测量骨吸收标志物,可能有助于识别绝经过渡期骨强度损失最大的女性。
局限性
- 原文未述局限性
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
UNLABELLED: We assessed whether a bone resorption marker, measured early in the menopause transition (MT), is associated with change in femoral neck size and strength during the MT. Higher levels of bone resorption were associated with slower increases in femoral neck size and faster decreases in femoral neck strength. PURPOSE: Composite indices of the femoral neck's ability to withstand compressive (compression strength index, CSI) and impact (impact strength index, ISI) forces integrate DXA-derived femoral neck width (FNW), bone mineral density (BMD), and body size. During the menopause transition (MT), FNW increases, and CSI and ISI decrease. This proof-of-concept study assessed whether a bone resorption marker, measured early in the MT, is associated with rates of change in FNW, CSI and ISI during the MT. METHODS: We used previously collected bone resorption marker (urine collagen type I N-telopeptide [U-NTX]) and femoral neck strength data from 696 participants from the Study of Women's Health Across the Nation (SWAN), a longitudinal study of the MT in a multi-ethnic cohort of community-dwelling women. RESULTS: Adjusted for MT stage (pre- vs. early perimenopause), age, body mass index (BMI), bone resorption marker collection time, and study site in multivariable linear regression, bone resorption in pre- and early perimenopause was not associated with transmenopausal decline rate in femoral neck BMD. However, each standard deviation (SD) increase in bone resorption level was associated with 0.2% per year slower increase in FNW (p = 0.03), and 0.3% per year faster declines in CSI (p = 0.02) and ISI (p = 0.01). When restricted to women in early perimenopause, the associations of bone resorption with change in FNW, CSI, and ISI were similar to those in the full sample. CONCLUSIONS: Measuring a bone resorption marker in pre- and early perimenopause may identify women who will experience the greatest loss in bone strength during the MT.
引用
- Shieh A, Ishii S, Greendale GA, et al. A bone resorption marker as predictor of rate of change in femoral neck size and strength during the menopause transition. Osteoporos Int. 2019. PMID: 31473793. doi:10.1007/s00198-019-05099-z
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。